Investment Rating - The investment rating for the company is downgraded to "Buy" with a target price of HKD 2.3, representing a potential upside of 9% from the current stock price of HKD 2.08 [1][6]. Core Insights - The domestic milk powder business continues to face pressure due to a significant decline in the birth rate, with the 2025 birth population projected at 79.2 million, a 17% year-on-year decrease [1][2]. - The company reported a revenue of RMB 3.89 billion for the first half of 2025, a 5.6% increase year-on-year, and a net profit of RMB 181 million, up 21.4% year-on-year, driven by overseas goat milk powder sales [2][3]. - The gross margin for the first half of 2025 was 41.9%, down 1.5 percentage points year-on-year, with goat milk powder and cow milk powder margins also declining [3]. Financial Summary - Revenue projections for 2025, 2026, and 2027 are adjusted to RMB 2.5 billion, RMB 2.6 billion, and RMB 2.9 billion respectively, with corresponding EPS estimates of HKD 0.16, HKD 0.16, and HKD 0.18 [1][4]. - The company’s financial performance shows a decline in domestic goat milk powder revenue by 8.9% and cow milk powder revenue by 14.9% in the first half of 2025 [2][3]. - The average P/E ratio for comparable companies is estimated at 11.7x, with the company assigned a P/E of 13x due to its overseas business development [12]. Valuation Analysis - The DCF valuation method estimates a reasonable market value of HKD 2.4 based on a WACC of 7.2% and a short-term growth rate of 4% [12]. - The target price of HKD 2.3 is derived from a combination of comparable company analysis and DCF valuation, indicating a potential upside from the current market price [12].
澳优：国内奶粉业务仍然承压-20260130